Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group | Synapse

May 28, 2008Open Access

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Postoperative cisplatin-based chemotherapy significantly improves survival in patients with NSCLC.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Pignon et al. (Wed,) studied this question.

synapsesocial.com/papers/69d7c6f005ee2ba81dbede0f https://doi.org/https://doi.org/10.1200/jco.2007.13.9030

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature2006 · 30 citations
2GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide, Version 1.02001 · 538 citations
3Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy1992 · 2,192 citations
4Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials1995 · 2,859 citations
5Adjuvant Therapy for Early Lung Cancer: Reflections and Perspectives2006 · 6 citations